How do the primary cultures of human umblical endothelium become resistant to vero toxins ?

人类脐带内皮细胞的原代培养物如何对维罗毒素产生抵抗力?

基本信息

  • 批准号:
    10670274
  • 负责人:
  • 金额:
    $ 1.66万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1998
  • 资助国家:
    日本
  • 起止时间:
    1998 至 1999
  • 项目状态:
    已结题

项目摘要

The endothelial cell damage by Shiga toxin (Stx) -1 / -2, both of which are produced by enterohemorrhagic E. coli, has been believed to the crucial for the pathogenesis of hemolytic uremic syndrome. In in vitro systems, however, Stxs were hardly toxic against various human endothelial cells such as umbilical vein endothelial cells (HUVEC). To our surprise, the fresh primary cultures of HUVEC, appeared to be sensitive to merely pM order of Stxs, whereas they rendered resistant during passage of only 1-2 weeks. Moreover, apoptosis is apparently involved in the damage of the primary culture cells, but not of passaged ones, as shown by the annexin V stain, TUNEL or DNA fragmentation, despite that the well-established function of Stxs is the inhibition of protein synthesis. Concerning the intracellular event in apoptosis, the activation of caspase -3 was observed by immunoblotting, and correspondingly, the inhibitor of caspase-3 raised the viability of endothelial cells after Stx treatment. Common upstream cascades for apoptosis such as fas stimulation, mitochondria discharge and nitric oxide synthesis were examined and found not be engaged, indicating a novel unique path may be at work here. Although the mechanism underling the resistance of the passaged HUVEC is still unclear, the possible candidates of extracellular and intracellular factors may be IFN-αand bcl-xL, respectively, according to our data
肠出血性大肠杆菌产生的志贺毒素(STX)-1/-2对血管内皮细胞的损伤被认为是溶血性尿毒症综合征发病的关键。然而,在体外系统中,STX对各种人内皮细胞,如脐静脉内皮细胞(HUVEC)几乎没有毒性。令我们惊讶的是,HUVEC的新鲜原代培养物似乎仅对Pm顺序的STX敏感,而它们在传代仅1-2周时就产生了抗性。此外,尽管Stxs的功能是抑制蛋白质合成,但通过Annexin V染色、TUNEL或DNA片段化显示,细胞凋亡明显参与了原代培养细胞的损伤,而不是传代细胞的损伤。对于细胞内的凋亡事件,免疫印迹法观察到caspase-3的激活,相应地,caspase-3的抑制剂提高了STX处理后内皮细胞的活力。对Fas刺激、线粒体放电和一氧化氮合成等常见的上游凋亡级联反应进行了研究,发现它们不参与其中,表明一条新的独特途径可能在这里发挥作用。尽管传代的人脐静脉内皮细胞耐药的机制尚不清楚,但根据我们的数据,细胞外和细胞内因子可能分别是干扰素-α和bcl-xl。

项目成果

期刊论文数量(19)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
D.Chakravortty et al: "Cytoskeletal alterations in lipopolysacchride-induced bovine vascular endothelial cell injury and its prevention by sodium arsenite"Clin.Diag.Lab.Immunol.. 7. 218-225 (2000)
D.Chakravortty 等人:“脂多糖诱导的牛血管内皮细胞损伤的细胞骨架改变及其通过亚砷酸钠的预防”Clin.Diag.Lab.Immunol..7.218-225(2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N.Koide et al.: "The expression of Fas and Fas ligand on mouse renal tubular epithelial cells in the generalized Shwartzman reaction and its relation of their apoptosis"Infection and Immunity. 67. 4112-4118 (1999)
N.Koide等:“广义Shwartzman反应中小鼠肾小管上皮细胞上Fas和Fas配体的表达及其与细胞凋亡的关系”感染与免疫。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
G.Z.Jiang,: "Role of CD86 (B7-2) in triggering of antigen-specific IgE antibody response by lipopolysaccharide." FEMS Immunol.Med.Microbiol.21. 303-311 (1998)
G.Z.Jiang,:“CD86 (B7-2) 在脂多糖触发抗原特异性 IgE 抗体反应中的作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
N.Koide et al: "Exacerbation of vascular endothelial injuruy in the generalized Shwartzman reaction by the administration of anti-E-sekectub antibody"Micobiol.Immunol.. 44. 197-200 (2000)
N.Koide 等人:“通过施用抗 E-sekectub 抗体,在广义 Shwartzman 反应中加剧血管内皮损伤”Micobiol.Immunol.. 44. 197-200 (2000)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Yoshida, et al.: "Primary cultures of human endothelial cells are susceptible to low doses of Shiga toxins and undergo papooses."Journal of Infectious Diseases.. 180. 2048-2052 (1999)
T.Yoshida 等人:“人内皮细胞的原代培养物对低剂量的志贺毒素敏感并会发生 Papoose。”传染病杂志.. 180. 2048-2052 (1999)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YOSHIDA Tomoaki其他文献

YOSHIDA Tomoaki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YOSHIDA Tomoaki', 18)}}的其他基金

Comprehensive analysis of bacterial factors involved in enterohemorrhagic E. coli infection to human colon epithelial cells for a preventive approach
肠出血性大肠杆菌感染人结肠上皮细胞的细菌因素综合分析及预防
  • 批准号:
    14570248
  • 财政年份:
    2002
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Infection mechanism of E.coli 0157 to native human colon epithelial cells
大肠杆菌0157对天然人结肠上皮细胞的感染机制
  • 批准号:
    12670268
  • 财政年份:
    2000
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Molecular definition of cellular states in the vascular endothelium
血管内皮细胞状态的分子定义
  • 批准号:
    DP230102958
  • 财政年份:
    2023
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Discovery Projects
Vascular endothelium-specific PAR2: mechanisms and effects
血管内皮特异性 PAR2:机制和作用
  • 批准号:
    461655
  • 财政年份:
    2022
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Operating Grants
Ex vivo simulation of the vascular endothelium during exercise and agonist activation
运动和激动剂激活期间血管内皮的离体模拟
  • 批准号:
    574494-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 1.66万
  • 项目类别:
    University Undergraduate Student Research Awards
The differential effect of oral anticoagulant types on the coagulant phenotype of vascular endothelium.
口服抗凝剂类型对血管内皮凝血表型的不同影响。
  • 批准号:
    MR/V037633/1
  • 财政年份:
    2021
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Research Grant
Targeting vascular endothelium for muscular dystrophy therapy
靶向血管内皮治疗肌营养不良症
  • 批准号:
    10379330
  • 财政年份:
    2021
  • 资助金额:
    $ 1.66万
  • 项目类别:
The role of vascular endothelium in BAT expansion and remodeling
血管内皮在 BAT 扩张和重塑中的作用
  • 批准号:
    10406295
  • 财政年份:
    2020
  • 资助金额:
    $ 1.66万
  • 项目类别:
The role of vascular endothelium in BAT expansion and remodeling
血管内皮在 BAT 扩张和重塑中的作用
  • 批准号:
    10627979
  • 财政年份:
    2020
  • 资助金额:
    $ 1.66万
  • 项目类别:
Analysis of coagulation and fibrinolytic functions and vascular endothelium-platelet interaction using disease-specific iPS cells
使用疾病特异性 iPS 细胞分析凝血和纤溶功能以及血管内皮-血小板相互作用
  • 批准号:
    20K08710
  • 财政年份:
    2020
  • 资助金额:
    $ 1.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of vascular endothelium in BAT expansion and remodeling
血管内皮在 BAT 扩张和重塑中的作用
  • 批准号:
    10888081
  • 财政年份:
    2020
  • 资助金额:
    $ 1.66万
  • 项目类别:
The role of vascular endothelium in BAT expansion and remodeling
血管内皮在 BAT 扩张和重塑中的作用
  • 批准号:
    10039668
  • 财政年份:
    2020
  • 资助金额:
    $ 1.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了